Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tarsus Pharmaceuticals Inc shares valued at $332,220 were sold by Azamian Bobak R. on Sep 24 ’25. At $55.37 per share, Azamian Bobak R. sold 6,000 shares. The insider’s holdings dropped to 812,106 shares worth approximately $55.39 million following the completion of this transaction.
Also, Bobak Azamian Living Trust purchased 6,000 shares, netting a total of over 332,208 in proceeds.
Before that, LINK WILLIAM J PHD had sold 27,116 shares from its account. In a trade valued at $1,545,612, the Director traded Tarsus Pharmaceuticals Inc shares for $57.00 each. Upon closing the transaction, the insider’s holdings decreased to 27,116 shares, worth approximately $9.78 million.
As of November 20, 2023, Goldman has initiated its “Neutral” rating for TARS. Earlier on July 18, 2023, William Blair initiated its rating. Their recommendation was “an Outperform” for TARS stock.
Analyzing TARS Stock Performance
On last trading session, Tarsus Pharmaceuticals Inc [NASDAQ: TARS] plunged -4.62% to $68.2. The stock’s lowest price that day was $67.5, but it reached a high of $71.9499 in the same session. During the last five days, there has been a surge of approximately 1.01%. Over the course of the year, Tarsus Pharmaceuticals Inc shares have jumped approximately 44.19%. Shares of the company reached a 52-week high of $76.81 on 10/16/25 and a 52-week low of $38.51 on 08/01/25.
Support And Resistance Levels for Tarsus Pharmaceuticals Inc (TARS)
According to the 24-hour chart, there is a support level at 66.48, which, if violated, would cause prices to drop to 64.75. In the upper region, resistance lies at 70.94. The next price resistance is at 73.67. RSI (Relative Strength Index) is 53.31 on the 14-day chart, showing neutral technical sentiment.
Is Tarsus Pharmaceuticals Inc subject to short interest?
Stocks of Tarsus Pharmaceuticals Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.61 million shares to 7.03 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 7.63 million shares. A decline of -8.67% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 10.32 of the overall float, the days-to-cover ratio (short ratio) decline to 10.32.
Which companies own the most shares of Tarsus Pharmaceuticals Inc (TARS)?
In terms of Tarsus Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 88 in the next 12 months, up nearly 23.08% from the previous closing price of $71.5. Analysts anticipate Tarsus Pharmaceuticals Inc stock to reach 88 by 2025, with the lowest price target being 88. In spite of this, 4 analysts ranked Tarsus Pharmaceuticals Inc stock as Buy at the end of 2025.
